Brief: Ryvu Therapeutics Signs Grant Deal With Medical Research Agency
April 23 (Reuters) - Ryvu Therapeutics SA RVU.WA: SIGNS GRANT DEAL WITH MEDICAL RESEARCH AGENCY PROJECT AIMS TO DEVELOP NEW GENERATION PAYLOADS FOR ADC IN ONCOLOGY TOTAL NET VALUE OF PROJECT IS PLN 13.2 MILLION RECOMMENDED GRANT VALUE IS PLN 9.9 MILLION Source text: ID:nEM2nqHkra Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys